About European Pharmaceutical Review

Overview

Overview

European Pharmaceutical Review is the leading publication for up-to-the-minute information on all aspects of drug analysis, formulation, delivery, manufacturing and regulation. Published bi-monthly, each issue delivers high-level technical and business contributions from the world’s leading pharmaceutical scientists and business experts, coupled with a variety of features including interviews, updates and profiles.

Providing the industry with cutting-edge facts and analysis for 21 years, European Pharmaceutical Review remains faithful to the key aspects that serve its existing stakeholders so well. It delivers insights into current and emerging technologies, contributions from recognised figures in the life science community, and quality presentation that makes every issue a reference tool for laboratories and offices across the world.

Readership & circulation

ABC Audited, European Pharmaceutical Review is regularly distributed to 11,993* senior managers and key decision-makers in the pharmaceutical, life sciences and drug discovery industries predominantly across Europe, but also with a guaranteed circulation of 1,000 in the US. Typical job titles include Managing Directors, Procurement Directors, Heads of R&D, Senior Scientists, Laboratory Managers, Process Engineers, Chief Engineers, Production Directors, Plant Managers, Product Managers, Quality Assurance Managers and Quality Control Managers. Pharmaceutical manufacturers are a core component of our readership.

Passed down through the management chain, we estimate that the total readership of European Pharmaceutical Review is 30,000 for each issue. This represents a highly targeted advertising opportunity for companies who wish to influence the key decision-makers in what is a vitally important industry.

* Circulation of 11,993 (for the 6 issues distributed between 1 January and 31 December 2015).

The Team

Our team

Meet the team who manage & contribute to European Pharmaceutical Review:

Editorial Board

We are delighted to introduce the European Pharmaceutical Review Editorial Board. Each member has been selected for their expertise and knowledge of the industry and help to shape and guide our editorial content, bringing the very latest news, technologies and breakthroughs to our readers:

  • Sheraz Gul, Head of Assay Development & Screening at the Fraunhofer Institute for Molecular Biology and Applied Ecology
  • Don Clark, Pfizer Global Supply
  • Michael J. Miller, President, Microbiology Consultants
  • Michael H. Elliott, CEO, Atrium Research & Consulting
  • David Elder, Director Externalisation Group, GlaxoSmithKline
  • Matthew Moran, Director, BioPharmaChem, Ireland
  • Jose Manuel Amigo Rubio, Associate Professor, Faculty of Life Sciences, University of Copenhagen

Published by

About Russell Publishing

Russell Publishing Ltd is a leading international publisher across a range of quarterly, bi-monthly and monthly titles, ranging from finance to pharmaceuticals and food to transport. Established since 1992, each title enjoys wide sector recognition by both advertisers and subscribers alike.

In addition to our leading publications, throughout the year we are responsible for producing conferences, roundtable discussions, newsletters and supplements for the industries we serve. Each of these products contributes towards the overall strategy of becoming an indispensable partner to all of our target customers.

For further information on Russell Publishing Ltd, please visit www.russellpublishing.com

Advisory Board

Send this to a friend